Editorial Commentary
Updates on the preoperative immunotherapy for triple-negative breast cancer
Translational Breast Cancer Research
2023;
4:
17
(30 April 2023)
Review Article
Narrative review on the role of immunotherapy in early triple negative breast cancer: unveiling opportunities and overcoming challenges
Translational Breast Cancer Research
2023;
4:
16
(30 April 2023)
Review Article
HER2-low breast cancer: insights on pathological testing
Translational Breast Cancer Research
2023;
4:
15
(30 April 2023)
Review Article
Breast biopsy techniques in a global setting—clinical practice review
Translational Breast Cancer Research
2023;
4:
14
(30 April 2023)
Review Article
Key points of anti-tumor treatment in breast cancer patients with SARS-CoV-2 infection
Translational Breast Cancer Research
2023;
4:
13
(30 April 2023)
Review Article
The association between perioperative opioids and breast cancer recurrence: a narrative review of the literature
Translational Breast Cancer Research
2023;
4:
12
(30 April 2023)
Original Article
Antibody-drug conjugate monotherapy refines the oncological efficacy as compared to therapy of physicians’ choices in advanced breast cancers: a systematic review and meta-analysis
Translational Breast Cancer Research
2023;
4:
11
(30 April 2023)
Original Article
Efficacy and safety of abemaciclib-based therapy versus tucidinostat-based therapy after progression on palbociclib in patients with HR+HER2− metastatic breast cancer
Translational Breast Cancer Research
2023;
4:
10
(30 April 2023)
